"Endometrial Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
| Descriptor ID |
D016889
|
| MeSH Number(s) |
C04.588.945.418.948.585 C13.351.500.852.762.200 C13.351.937.418.875.200
|
| Concept/Terms |
Endometrial Neoplasms- Endometrial Neoplasms
- Endometrial Neoplasm
- Neoplasm, Endometrial
- Neoplasms, Endometrial
Endometrial Carcinoma- Endometrial Carcinoma
- Carcinoma, Endometrial
- Carcinomas, Endometrial
- Endometrial Carcinomas
- Endometrial Cancer
- Cancer, Endometrial
- Cancers, Endometrial
- Endometrial Cancers
- Endometrium Cancer
- Cancer, Endometrium
- Cancers, Endometrium
- Cancer of the Endometrium
- Carcinoma of Endometrium
- Endometrium Carcinoma
- Endometrium Carcinomas
- Cancer of Endometrium
- Endometrium Cancers
|
Below are MeSH descriptors whose meaning is more general than "Endometrial Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Endometrial Neoplasms".
This graph shows the total number of publications written about "Endometrial Neoplasms" by people in this website by year, and whether "Endometrial Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 1 | 4 |
| 1999 | 5 | 0 | 5 |
| 2000 | 5 | 1 | 6 |
| 2001 | 8 | 0 | 8 |
| 2002 | 2 | 0 | 2 |
| 2003 | 3 | 1 | 4 |
| 2004 | 5 | 0 | 5 |
| 2005 | 1 | 0 | 1 |
| 2006 | 6 | 0 | 6 |
| 2007 | 7 | 0 | 7 |
| 2008 | 0 | 1 | 1 |
| 2009 | 5 | 0 | 5 |
| 2010 | 1 | 0 | 1 |
| 2011 | 3 | 1 | 4 |
| 2012 | 5 | 0 | 5 |
| 2013 | 4 | 1 | 5 |
| 2014 | 4 | 0 | 4 |
| 2015 | 5 | 1 | 6 |
| 2016 | 8 | 0 | 8 |
| 2017 | 8 | 1 | 9 |
| 2018 | 10 | 0 | 10 |
| 2019 | 9 | 0 | 9 |
| 2020 | 6 | 1 | 7 |
| 2021 | 8 | 1 | 9 |
| 2022 | 13 | 0 | 13 |
| 2023 | 10 | 0 | 10 |
| 2024 | 6 | 1 | 7 |
| 2025 | 10 | 1 | 11 |
| 2026 | 6 | 0 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Endometrial Neoplasms" by people in Profiles.
-
Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers. Gynecol Oncol. 2026 Sep; 212:134-144.
-
Racial Differences in Sonographic Evaluation in Suspected Cases of Endometrial Neoplasia. JAMA Netw Open. 2026 08 03; 9(8):e2627283.
-
Androgen receptor as a therapeutic target in endometrial cancer: a narrative review. Int J Gynecol Cancer. 2026 06; 36(6):104698.
-
Optimization of methylated DNA markers to rule out endometrial cancer in patients with abnormal uterine bleeding. Gynecol Oncol. 2026 May; 208:91-99.
-
DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix. J Immunother Cancer. 2026 Feb 11; 14(2).
-
CD73 restrains mutant ß-catenin oncogenic activity in endometrial carcinomas. JCI Insight. 2026 01 23; 11(2).
-
A Deeper Dive into POLE -Mutated Endometrial Carcinomas : The Contributions and Consequences of Tumor Mutational Burden. Am J Surg Pathol. 2026 Mar 01; 50(3):301-312.
-
Clinical outcomes with triple tandem brachytherapy for medically inoperable endometrial cancer in a high-risk patient population. Brachytherapy. 2026 Mar-Apr; 25(2):283-290.
-
Pathogenic POLE-Mutated Endometrial Carcinomas With a Nonultramutated Genome. Mod Pathol. 2026 Feb; 39(2):100946.
-
Race and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral center. Gynecol Oncol. 2025 10; 201:203-209.